QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

AVBP

QT80ArriVent BioPharma, Inc. Common Stock
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
31.74
+0.38+1.21%
OverviewShort InterestFilings
AVBPQT80ArriVent BioPharma, Inc. Common Stock·NASDAQ
OverviewShort InterestFilings
31.74+1.21%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own22.31%
Shs Outstand46.57M
Perf Week5.10%
Market Cap1.46BForward P/E-EPS next Y-3.44Insider Trans0.00%Shs Float-Perf Month21.38%
Enterprise Value1.40BPEG-EPS next Q-0.98Inst Own-Short Float-Perf Quarter38.85%
Income-150148625.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y37.34%
Sales-P/B4.36EPS next Y14.88%ROA-41.58%Short Interest-Perf YTD57.75%
Book/sh-P/C-EPS next 5Y-ROE-48.98%52W High33.62 -5.59%Perf Year27.06%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-48.36%52W Low16.10 97.14%Perf 3Y-
Dividend Est.-EV/EBITDA-9.63Sales past 3/5Y-Gross Margin0.00%Volatility3.53% 3.95%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM-Oper. Margin0.00%ATR (14)1.65Perf 10Y-
Dividend Ex-Date-Quick Ratio13.95Sales Y/Y TTM-Profit Margin0.00%RSI (14)60.90Recom2.00
Dividend Gr. 3/5Y-Current Ratio13.95EPS Q/Q49.47%SMA206.47%Beta1.26Target Price45.00
Payout0.00%Debt/Eq0.00Sales Q/Q-SMA507.96%Rel Volume1.68Prev Close31.36
Employees52LT Debt/Eq-EarningsAug 10SMA20035.69%Avg Volume511.09KPrice31.74
IPO DateJan 26, 2024Option/ShortYes / YesEPS/Sales Surpr.-9.09% -Net Debt/EBITDA0.42Volume859,253Change1.21%
Analyst Ratings
DateActionAnalystRatingTarget
May-29-26ReiteratedTruist Financial$43 → $45
Dec-10-25InitiatedBTIG on firmonertinib potentialBuy$45
Nov-25-25InitiatedTruistBuy$43
Jul-10-25ResumedGoldman SachsBuy$33
Sep-10-24ReiteratedH.C. Wainwright$30 → $36
Aug-16-24ReiteratedH.C. Wainwright$30
Jul-22-24ReiteratedOppenheimer$35
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Insider Trading Volume
$33.72$30.36$26.99$23.62$20.26● Close Price0.00M3.25M6.49M9.74M12.98MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
HILLHOUSE INVESTMENT MANAGEMENT, LTD.10% OwnerDec 10 '25Sale23.37555,55512,983,3203,929,117Feb 03 12:00 AM
LaChapelle RobinChief Operating OfficerJul 11 '25Option Exercise2.2822,30650,858135,736Jul 15 12:00 AM
HILLHOUSE INVESTMENT MANAGEMENT, LTD.10% OwnerJan 30 '24Buy18.00555,5559,999,9904,484,672Feb 01 12:00 AM
ORBIMED ADVISORS LLCdirector, 10 percent owner:Jan 30 '24Buy18.00222,2223,999,9961,513,664Jan 31 12:00 AM
GORDON CARL Ldirector, 10 percent owner:Jan 30 '24Buy18.00222,2223,999,9961,513,664Jan 31 12:00 AM
HEALY JAMESDirectorJan 30 '24Buy18.00444,4447,999,9921,696,752Jan 31 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR